Subbaramaiah, Kotha <br/><br/>
Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1.  [electronic resource] 

 -  Cancer prevention research (Philadelphia, Pa.)  Oct 2012 
 - 1183-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Retracted Publication 
<br/><br/><label>ISSN: </label>1940-6215 
<br/><br/><label>Standard No.: </label>10.1158/1940-6207.CAPR-12-0201  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipose Tissue--cytology<br/>Animals<br/>Aromatase--chemistry<br/>BRCA1 Protein--genetics<br/>Blotting, Western<br/>Breast Neoplasms--drug therapy<br/>Cells, Cultured<br/>Chromatin Immunoprecipitation<br/>Cyclic AMP--metabolism<br/>Cyclic AMP-Dependent Protein Kinases--metabolism<br/>Dinoprostone--metabolism<br/>Electrophoretic Mobility Shift Assay<br/>Female<br/>Gene Expression Regulation, Enzymologic<br/>Humans<br/>Hydroxyprostaglandin Dehydrogenases--genetics<br/>Hypoglycemic Agents--pharmacology<br/>Mice<br/>PPAR gamma--agonists<br/>Pioglitazone<br/>Promoter Regions, Genetic--genetics<br/>RNA, Messenger--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Snail Family Transcription Factors<br/>Thiazolidinediones--pharmacology<br/>Transcription Factors--genetics